|
| |
Image Results
Loading...
Loading...
EOVIST Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
Eovist Injection and Resovist Injection: two new liver-specific ...
Eovist Injection (gadolinium-EOB-DTPA) is selectively taken up by hepatocytes, which will increase the signal intensity of normal liver parenchyma on ...
http://www.ncbi.nlm.nih.gov/pubmed/10887650...
|
eovist (Gadoxetate Disodium) injection, solution for intravenous ...
These highlights do not include all the information needed to use eovist safely and effectively. See full prescribing information for eovist. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=7964...
|
Gadoxate disodium: gadolinium EOB DTPA, gadoxetic acid, Gd-EOB-DTPA.
Apart from covering Eovist (Schering AG), the EU patent also covered gadobenate ... In its 2002 Annual Report, Schering predicted that Eovist has the ...
http://www.ncbi.nlm.nih.gov/pubmed/15230630...
|
Gadoxetic acid - Wikipedia, the free encyclopedia
13 Jul 2009 ... Its salt, gadoxetate disodium, is marketed as Eovist by Bayer HealthCare ... http://imaging.bayerhealthcare.com/html/eovist/index.html. ...
http://en.wikipedia.org/wiki/Gadoxetic_acid...
|
Stereospecific binding of MRI contrast agents to human serum ...
The water proton relaxation rate enhancement of the hepatospecific Gd-(S)-EOB- DTPA (Eovist) and of its (R) isomer in aqueous solutions free of protein, ...
http://www.ncbi.nlm.nih.gov/pubmed/11293414...
|
Centers for Medicare & Medicaid Services (CMS) Healthcare Common ...
EOVIST® is a paramagnetic contrast agent for MRI and contains the active ... tracking of EOVIST®, and would be "consistent with CMS' instructions to ...
http://www.cms.hhs.gov/MedHCPCSGenInfo/Downloads/April28th-D...
|
[New MR contrast media in liver diagnosis. Initial clinical ...
The purpose of this work is to describe our initial clinical experience (in 66 patients) with Resovist and Eovist, two new liver-specific MR contrast agents ...
http://www.ncbi.nlm.nih.gov/pubmed/8867429...
|
Thomas Jefferson University : Department of Radiology : Magnetic ...
Eovist, a new gadolinium contrast agent, is FDA approved specifically for evaluating ... Eovist is administered at reduced dose, so clarity of vascular ...
http://www.jefferson.edu/jmc/radiology/divisions/mri/service...
|
Customer Login : McKesson Corporate
Magnevist/Ultravist/Eovist Ordering. Ordering site for the specialty pharmaceuticals Magnevist, Ultravist and Eovist ...
http://www.mckesson.com/en_us/McKesson.com/Customer%2BLogin/...
|
[Current status of the clinical development of MR contrast media]
The paramagnetic hepatobiliary CM Teslascan, Eovist and MultiHance are in clinical trials (phase II and III). They improve tumour detection and ...
http://www.ncbi.nlm.nih.gov/pubmed/9465947...
|
|